This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Assess which Sp 500 fund is best for IRAs in 2024 using simple criteria, performance context, and fee awareness for smarter selection.
24,414 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
KORU, a triple-leveraged bet on South Korea stocks, sank 42% in a single trading day as chipmakers slid and risk appe...
Grayscale Investments disclosed on July 2, 2026 that its CFO for the Ethereum Staking Mini ETF is leaving after seven...
When expenses shrink, choices grow. A lower cost of living can turn basic stability into genuine freedom—time for fam...
Salesforce plans up to $25 billion in debt to fund an accelerated share repurchase that would buy back roughly 14% of...
A sudden burst in DRAM-focused ETFs outpaced the broader semiconductor market this month, but market watchers warn a ...
Moderna rose to fame with COVID-19 vaccines, but the road to sustained profits is more complex. This guide breaks dow...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
Retirees chasing amlp’s 7.9% yield face a tug-of-war between high income and the risk of payout gaps. This deep dive ...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
In a crowded field of weekly pay ETFs, Roundhill’s lineup appears to deliver cash income more reliably, yet investors...